CRISPR Medicine News, 20 January 2021 | Clinical Trial Update - CRISPR Medicine

STL Genome Editing 2021…Virtually A New Beginning.

21-22 January 2021.

Keynote Speaker: Charlie Gersbach, Ph.D., Rooney Family Associate Professor of Biomedical Engineering, Duke University.

Program and Registration

Clinical Trial Update – CRISPR-Engineered Dual Specificity CAR-T Therapy

This week’s trial update looks at a universal dual specificity CD19 and CD20/CD22 CAR-T cell immunotherapy that is being developed for relapsed or refractory leukaemia and lymphoma. Read it here.

Career CRISPR Medicine

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at We love hearing from readers!

Happy Reading!


p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.


CRISPR QC pioneers streamlined and automated CRISPR quality control tools to accelerate research while improving accuracy and performance.